Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/3/25 16:15 | 1/2/25 | XLO | Health | Drug | Pharmaceutical Preparations | Frankenfield Christopher James | MA | O | CFO | S.d | -7 | 0.9837 | 0 | -7 | -36 | 12 | D | ||||||||||||||
1/3/25 16:15 | 1/2/25 | XLO | Health | Drug | Pharmaceutical Preparations | Brennan Kevin M. | MA | O | SVP,FINA | S.d | -2 | 0.9837 | 0 | -2 | -36 | 3 | D | ||||||||||||||
2/9/24 16:33 | 2/8/24 | XLO | Health | Drug | Pharmaceutical Preparations | Atlas Venture Fund Xi, L.P. | MA | T | S | -1 | 0.6400 | 0 | -1 | 0 | 2,754 | M | |||||||||||||||
1/16/24 18:16 | 1/11/24 | XLO | Health | Drug | Pharmaceutical Preparations | Atlas Venture Fund Xi, L.P. | MA | T | S.m | -4 | 0.8502 | 0 | -4 | 0 | 2,755 | M |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |